INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 360 filers reported holding INTELLIA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.02 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $507,000 | -14.5% | 4,289 | -3.1% | 0.03% | -21.2% |
| Q3 2021 | $593,000 | -18.1% | 4,424 | -1.0% | 0.03% | -17.5% |
| Q2 2021 | $724,000 | +262.0% | 4,470 | +79.2% | 0.04% | +233.3% |
| Q1 2021 | $200,000 | +40.8% | 2,494 | -75.9% | 0.01% | -25.0% |
| Q4 2018 | $142,000 | -48.9% | 10,367 | +6.8% | 0.02% | -48.4% |
| Q3 2018 | $278,000 | +34.3% | 9,707 | +28.0% | 0.03% | +29.2% |
| Q2 2018 | $207,000 | – | 7,581 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 744,160 | $54,078,000 | 5.79% |
| Discovery Value Fund | 986,173 | $71,665,000 | 5.28% |
| Ally Bridge Group (NY) LLC | 60,000 | $4,360,000 | 3.23% |
| MPM BioImpact LLC | 159,409 | $11,584,000 | 3.11% |
| ARK Investment Management | 8,981,029 | $652,651,000 | 2.72% |
| Elmwood Wealth Management, Inc. | 67,599 | $4,912,000 | 2.52% |
| Nikko Asset Management Americas, Inc. | 2,872,269 | $192,442,000 | 1.41% |
| Frazier Life Sciences Management, L.P. | 203,684 | $14,802,000 | 1.26% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 111,440 | $8,098,000 | 1.22% |
| Merlin Capital, Inc | 11,575 | $841,000 | 1.11% |